Neuroectodermal and Neural Tumors

  • Cyril Fisher
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

The category of neuroectodermal and neural tumors includes tumors outside the central nervous system, supposedly derived from primitive neural crest cells, in which the principal line of differentiation is neuroectodermal, or toward nerve cells (as opposed to cells of the nerve sheath). These tumors also sometimes have neuroendocrine features, although many are undifferentiated. The less differentiated neoplasms tend to occur in childhood and include Ewing sarcoma and neuroblastoma.

Ewing sarcoma and primitive peripheral neuroectodermal tumor are small round cell malignant neoplasms that are essentially the same entity but are considered to display a spectrum of neuroectodermal differences, mostly at the ultrastructural or immunohistochemical level.

Suggested Reading

  1. Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer. 2009;100:1471–82.PubMedCrossRefGoogle Scholar
  2. Bridge JA, Cushman-Vokoun AM. Molecular diagnostics of soft tissue tumors. Arch Pathol Lab Med. 2011;135:588–601.PubMedGoogle Scholar
  3. Kapadia SB, Frisman DM, Hitchcock CL, Ellis GL, Popek EJ. Melanotic neuroectodermal tumor of infancy. Clinicopathological, ­immunohistochemical and flow cytometric study. Am J Surg Pathol. 1993;17:566–73.PubMedCrossRefGoogle Scholar
  4. Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, et al. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2008;51:334–8.PubMedCrossRefGoogle Scholar
  5. Mackintosh C, Madoz-Gurpide J, Ordonez JL, Osuna D, Herrero-Martin D. The molecular pathogenesis of Ewing’s sarcoma. Cancer Biol Ther. 2010;9:655–67.PubMedCrossRefGoogle Scholar
  6. Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J. Advances in Ewing’s sarcoma research: where are we now and what lies ahead? Cancer Res. 2009;69:7140–50.PubMedCrossRefGoogle Scholar
  7. Plaza JA, Wakely Jr PE, Moran C, Fletcher CD, Suster S. Sclerosing paraganglioma: report of 19 cases of an unusual variant of neuroendocrine tumor that may be mistaken for an aggressive malignant neoplasm. Am J Surg Pathol. 2006;30:7–12.PubMedCrossRefGoogle Scholar
  8. Potratz J, Jurgens H, Craft A, Dirksen U. Ewing sarcoma: biology-based therapeutic perspectives. Pediatr Hematol Oncol. 2012;29:12–27.PubMedCrossRefGoogle Scholar
  9. Rushing EJ, Bouffard JP, McCall S, Olsen C, Mena H, Sandberg GD, et al. Primary extracranial meningiomas: an analysis of 146 cases. Head Neck Pathol. 2009;3:116–30.PubMedCrossRefGoogle Scholar
  10. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children’s Cancer Group. Cancer. 2001;92:2451–61.PubMedCrossRefGoogle Scholar
  11. Sonobe H, Ro J, Hicks J, Ordonez N, Mackay B, Gomez A, et al. Malignant ectomesenchymoma of soft tissue: evaluation of immunocytochemical and ultrastructural features. Lab Invest. 1997;76:61.Google Scholar
  12. Thway K, Fisher C. Diffuse ganglioneuromatosis in small intestine associated with neurofibromatosis type 1. Ann Diagn Pathol. 2009;13:50–4.PubMedCrossRefGoogle Scholar
  13. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51:127–39.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Cyril Fisher
    • 1
  1. 1.Department of HistopathologyThe Royal Marsden HospitalLondonUK

Personalised recommendations